Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 75, Issue 7, 2020, Pages 1730-1741

  Zhang, Jin jin ^a   Dong, Xiang ^a   Cao, Yi yuan ^a   Yuan, Ya dong ^b   Yang, Yi bin ^a   Yan, You qin ^c   Akdis, Cezmi A ^d   Gao, Ya dong ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Wuhan No7 Hospital   (China)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

allergy; COVID 19; eosinophil; risk factor; SARS CoV 2

Indexed keywords

C REACTIVE PROTEIN; D DIMER; PROCALCITONIN; SERUM AMYLOID A;

ABDOMINAL PAIN; ADULT; AGED; ALLERGIC RHINITIS; ANOREXIA; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; COUGHING; CURRENT SMOKER; DECREASED APPETITE; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DYSPNEA; ELECTRONIC MEDICAL RECORD; EOSINOPENIA; EOSINOPHIL COUNT; ERUCTATION; FATIGUE; FEMALE; FEVER; FOOD ALLERGY; HOSPITAL PATIENT; HUMAN; HYPERTENSION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX RATIO; URTICARIA; VOMITING; BETACORONAVIRUS; BLOOD; CHINA; COMMUNITY ACQUIRED INFECTION; CORONAVIRUS INFECTION; EOSINOPHIL; GENETICS; HOSPITALIZATION; MIDDLE AGED; PANDEMIC; PATHOPHYSIOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; C-REACTIVE PROTEIN; CHINA; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CORONAVIRUS INFECTIONS; DIABETES MELLITUS; EOSINOPHILS; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; LYMPHOPENIA; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85080137864     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.14238     Document Type: Article

References (40)

1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585 [Epub ahead of print].
4. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020:2020.02.06.20020974.
5. World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed February 19, 2020.
6. Tan WJ, Zhao X, Ma XJ, et al. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019–2020. China CDC Weekly. 2020;2:61-62.
7. Rambaut A. Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes, 2020–01-19. http://virological.org/t/preliminary-phylogenetic-analysis-of-11-ncov2019-genomes-2020-01-19/329. Accessed February 12, 2020.
8. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135.
9. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523.
10. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316 [Epub ahead of print].
11. Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012;185:281-285.
12. Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017;139:501-507.
13. Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev. 2011;242:69-90.
14. Baraldo S, Contoli M, Bazzan E, et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012;130:1307-1314.
15. Rowe RK, Gill MA. Asthma: the interplay between viral infections and allergic diseases. Immunol Allergy Clin North Am. 2015;35:115-127.
16. Gilles S, Blume C, Wimmer M, et al. Pollen exposure weakens innate defense against respiratory viruses. Allergy. 2020;75(3):576-587. https://doi.org/10.1111/all.14047 [Epub ahead of print].
17. Wu YH, Lai AC, Chi PY, et al. Pulmonary IL-33 orchestrates innate immune cells to mediate RSV-evoked airway hyperreactivity and eosinophilia. Allergy. 2020;75(4):818-830. https://doi.org/10.1111/all.14091 [Epub ahead of print].
18. Gavala ML, Bashir H, Gern JE. Virus/allergen interactions in asthma. Curr Allergy Asthma Rep. 2013;13:298-307.
19. Holt PG, Strickland DH, Sly PD. Virus infection and allergy in the development of asthma: what is the connection. Curr Opin Allergy Clin Immunol. 2012;12:151-157.
20. Leino A, Lukkarinen M, Turunen R, et al. Pulmonary function and bronchial reactivity 4 years after the first virus-induced wheezing. Allergy. 2019;74:518-526.
21. Svensson A, Nordström I, Rudin A, Bergström T, Eriksson K. Enveloped virus but not bacteria block IL-13 responses in human cord blood T cells in vitro. Scand J Immunol. 2012;75:409-418.
22. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706-1717.
23. Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. 2013;4:293.
24. Hu SS, Gao RL, Liu LS, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circ J. 2019;34:209-220.
25. Liu M, Liu SW, Wang LJ, et al. Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 2019;45:286-293.
26. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-2809.
27. Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407-418.
28. Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016;71:1170-1180.
29. 2LEN-DARE systematic review. Allergy. 2011;66:458-468.
30. Greenberg SB. Update on human rhinovirus and coronavirus infections. Semin Respir Crit Care Med. 2016;37:555-571.
31. Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol. 2018;163:845-853.
32. Han M, Rajput C, Ishikawa T, Jarman CR, Lee J, Small HMB. Animal models of respiratory viral infection related to asthma. Viruses. 2018;10(12):682.
33. Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136:81-86.
34. Erdem SB, Can D, Girit S, et al. Does atopy affect the course of viral pneumonia. Allergol Immunopathol. 2018;46:119-126.
35. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2019 (Country Profile: China). https://www.who.int/tobacco/surveillance/policy/country_profile/chn.pdf?ua=1. Accessed February 17, 2020.
36. Seys L, Widagdo W, Verhamme FM, et al. DPP4, the middle east respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66:45-53.
37. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875-879.
38. Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med. 2006;84:814-820.
39. Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6:271-276.
40. Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020. https://doi.org/10.1007/s11427-020-1637-5 [Epub ahead of print].